| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $613.5M | $602.2M | $659.7M |
| YoY Revenue Growth % | +1.9% | -8.7% | — |
| Gross Profit | $266.2M | $238.5M | — |
| Gross Margin % | 43.4% | 39.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $82.5M | $14.7M | $94.0M |
| Operating Margin % | 13.4% | 2.4% | 14.3% |
| Net Income (GAAP) | $19.2M | -$23.2M | $19.2M |
| EBITDA (Normalized) | $92.3M | $20.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $46.2M | $46.9M | $88.1M |
| Capital Expenditures (CapEx) | $12.3M | $6.8M | — |
| Free Cash Flow (FCF) | $33.9M | $40.1M | $88.1M |
| FCF Margin % | 5.5% | 6.7% | 13.4% |
| Return on Invested Capital (ROIC %) | 7.0% | 1.3% | — |
| Cash & Short-Term Equivalents | $37.2M | $56.1M | — |
| Total Debt (Short + Long Term) | $516.1M | $545.4M | — |
| Total Stockholders' Equity | $448.9M | $421.2M | — |